Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
{{output}}
Third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have shown impressive results in EGFR mutant lung cancer (LC) patients in terms of disease control rate with a positive impact on overall survival. Nevertheless, after m... ...
